Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-029552
Filing Date
2021-05-24
Accepted
2021-05-24 17:26:02
Documents
98
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ffntf-10q_20210331.htm   iXBRL 10-Q 2626817
2 EX-31.1 ffntf-ex311_30.htm EX-31.1 13467
3 EX-31.2 ffntf-ex312_31.htm EX-31.2 13534
4 EX-32.1 ffntf-ex321_32.htm EX-32.1 10939
  Complete submission text file 0001564590-21-029552.txt   12111640

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20210331.xsd EX-101.SCH 94391
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ffntf-20210331_cal.xml EX-101.CAL 84588
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ffntf-20210331_def.xml EX-101.DEF 267607
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20210331_lab.xml EX-101.LAB 601543
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20210331_pre.xml EX-101.PRE 466920
10 EXTRACTED XBRL INSTANCE DOCUMENT ffntf-10q_20210331_htm.xml XML 2787730
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56075 | Film No.: 21956275
SIC: 2833 Medicinal Chemicals & Botanical Products